Fluoxetine or placebo for patients with a recent stroke

Registry ID
EUCTR2011-005616-29
Source registry
EUCTR
Status
Completed
Phase
PHASE3
Sponsor
University of Edinburgh
Start date
2012-02-03
Completion date
2018-05-16
Last update
2026-08-16

Conditions

Summary

Is there a difference in the functional outcome, measured with the modified Rankin score, at 6 months between those treated with fluoxetine (20mg daily) for 6 months after stroke, and those treated with placebo?

Locations

View on source registry